IMMUNOMODULATING, METABOLIC AND CARDIOPROTECTIVE EFFECTS OF AT1-ANGIOTENSIN RECEPTORS BLOCKER LOSARTAN IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Teplyakov, A. T. [1 ]
Mayanskaya, S. D. [1 ]
Bolotskaya, L. A. [1 ]
Vdovina, T. V. [1 ]
Stepacheva, T. A. [1 ]
Kuznetsova, A., V [1 ]
Lukinov, A., V [1 ]
Derbeneva, N., V [1 ]
Frants, M., V [1 ]
Shilov, S. N. [1 ]
机构：
[1] Russian Acad Med Sci, State Univ, Sci Res Inst Cardiol, Tomsk Sci Ctr,Siberian Branch, Moscow 109801, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2009年 / 81卷 / 03期
关键词：
RANDOMIZED-TRIAL; CLINICAL STATUS; MORTALITY; ENALAPRIL; INTERVENTION; HYPERTENSION; IRBESARTAN; CAPTOPRIL; SURVIVAL; MODERATE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [41] Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry
    Iwase, Masanori
    Ohkuma, Toshiaki
    Fujii, Hiroki
    Oku, Yutaro
    Higashi, Taiki
    Oshiro, Ayaka
    Ide, Hitoshi
    Nakamura, Udai
    Kitazono, Takanari
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 201
  • [42] Severity and Outcome of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus and in Patients with Coronary Heart Disease
    Tziomalos, Konstantinos
    Bouziana, Stella
    Spanou, Marianna
    Kostaki, Stavroula
    Papadopoulou, Maria
    Poulou, Stella-Maria Angelo
    Tsopozidi, Maria
    Giampatzis, Vasilios
    Savopoulos, Christos
    Hatzitolios, Apostolos I.
    DIABETES, 2016, 65 : A115 - A115
  • [43] Effects of Periodontal Therapy on Metabolic Control in Patients With Type 2 Diabetes Mellitus and Periodontal Disease
    Wang, Tze-Fang
    Jen, I-An
    Chou, Chyuan
    Lei, Yen-Ping
    MEDICINE, 2014, 93 (28) : e292
  • [44] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [45] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180
  • [46] Management of coronary artery disease in patients with type 2 diabetes mellitus
    Srikanth S.
    Deedwania P.
    Current Cardiology Reports, 2007, 9 (4) : 264 - 271
  • [47] Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2
    Lerch, M
    Weidmann, P
    Ho, MP
    Gerber, P
    Eckenberger, P
    Kaemmereit, A
    Teuscher, AU
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (04) : 527 - 533
  • [48] TYPE 2 DIABETES MELLITUS IS ASSOCIATED WITH CAROTID ARTERY PLAQUES IN PATIENTS WITH PREMATURE CORONARY HEART DISEASE
    Gabriel Juarez-Rojas, J.
    Posadas-Romero, Carlos
    Martinez-Alvarado, Rocio
    Jorge-Galarza, Esteban
    Reyes-Barrera, Juan
    Gabriela Sanchez-Lozada, L.
    Torres-Tamayo, Margarita
    Medina-Urrutia, Aida X.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (06): : 301 - 309
  • [49] A supervised learning approach to predicting coronary heart disease complications in type 2 diabetes mellitus patients
    Giardina, Marisol
    Azuaje, Francisco
    McCullagh, Paul
    Harper, Roy
    BIBE 2006: SIXTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, 2006, : 325 - +
  • [50] Correlation between serum Galanin,Leptin and coronary heart disease in patients with type 2 diabetes mellitus
    李敏
    China Medical Abstracts(Internal Medicine), 2023, 40 (01) : 23 - 24
12345